glp 1 and shortness of breath Your guide to GLP-1 side effects Glucagon-like peptide-1 receptor: mechanisms and

doi: 10.1016/j.suc.2016.03.004

Switch to lukewarm water and limit showers to 10 minutes or less

The quick answer: Semaglutide is a GLP-1 receptor agonist an injectable (and now oral) drug FDA-approved for long-term, chronic weight management , producing the larger weight loss but at meaningfully higher cost

#longevity #geroscience #pulmonaryhypertension #biotech #aging 35Pharma To view or add a comment, sign in Insulin Icodec = Once-Weekly Insulin Revolution Remember it with this mnemonic: I-C-O-D-E-C I = Inject once weekly C = Convenience improved (fewer injections, better adherence) O = Optimized glycemic control D = Designed for long duration (7-day basal coverage) E = Eases treatment burden C = Changing diabetes care Insulin icodec is a novel once-weekly basal insulin analog developed to simplify diabetes management and potentially improve adherence compared with daily basal insulin regimens